New and old prognostic factors in polycythemia vera
Polycythemia vera is a chronic myeloproliferative disorder affecting people in the sixth decade of life. The disease is considered long-lasting; median survival exceeds 18 years.
PASSAMONTI, FRANCESCO
core
Polycythemia Vera and Cardiovascular Disease: A Mini Review. [PDF]
Mukai M, Aikawa T, Matsue Y, Minamino T.
europepmc +1 more source
Beyond atherosclerosis: polycythemia vera presenting as ST-elevation myocardial infarction-a case report. [PDF]
Panda A, Kumar S, Mishra SS.
europepmc +1 more source
[Progress in the study of polycythemia vera in children]. [PDF]
Hu LJ, Yang WY.
europepmc +1 more source
Distinct Longitudinal Patterns of Basal and Squamous Cell Carcinoma in Polycythemia Vera and Essential Thrombocythemia. [PDF]
Loscocco GG +5 more
europepmc +1 more source
Extensive bilateral pulmonary embolism revealing iron deficiency-masked JAK2-positive polycythemia vera: A case report. [PDF]
Ejjebli HE +4 more
europepmc +1 more source
A Therapeutic Dilemma: Catastrophic ST-Elevation Myocardial Infarction Following Antiplatelet Therapy Interruption in a Patient With JAK2-Positive Polycythemia Vera. [PDF]
Zarei B, Rezaei Latifi A, Salari M.
europepmc +1 more source
Patient-reported outcomes of symptom burden and quality of life in patients with polycythemia vera and essential thrombocythemia in Korea: A cross-sectional study. [PDF]
Cho Y.
europepmc +1 more source
Retroperitoneal and Pelvic Myeloid Sarcoma in a Patient With JAK2-Positive Polycythemia Vera: A Case Report. [PDF]
Hagigatian MM +4 more
europepmc +1 more source
Superior Mesenteric Artery Thrombosis as a Complication of Polycythemia Vera: A Case Report. [PDF]
Milić L +4 more
europepmc +1 more source

